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We report late diagnoses of cystic fibrosis (CF) in two men aged 61 and 65 years. At the time of presentation, both patients had significant
pulmonary disease. In each case two CFTR gene mutations were identified, including R117H on a background of a poly T genotype of 7T/
9T. Patients with two identified CFTR mutations which include the R117H/7T anomaly should be followed up routinely as they remain
susceptible to severe lung disease.
D 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Late diagnosis; R117H; 7T; Bronchiectasis1. Introduction
Over 1000 CFTR mutations have been identified and
classified into various functional classes according to the
mechanisms by which they produce quantitative or
qualitative changes in CFTR function. The amount of
functioning CFTR appears to be related to clinical status
with some Fmilder_ mutations presenting with congenital
absence of vas with or without mild respiratory disease [1–
4]. However the spectrum of mutations in the CFTR gene
gives rise to a very variable clinical phenotype that may not
be predictable from the genotype alone due to the
influences of other factors such as the environment and
the absence or presence of modulator genes.
We report late diagnoses of CF in two elderly men, both
of whom had an R117H mutation on a background of a poly
T genotype of 7T/9T.1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2005.09.009
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A 61-year-old man was admitted with a 7-month history
of progressive weight loss, dyspnoea, cough and fever.
There was no family history of cystic fibrosis (CF).
Ten years earlier, he had undergone an oesophagogas-
trectomy followed by chemotherapy for T3 N1 M0
oesophageal carcinoma. At the age of 27 years, he had
been investigated for male infertility and was found to have
obstructive azoospermia. On examination he was pyrexial
and cachectic with significant muscle bulk loss. He had mild
finger clubbing with coarse left basal crackles.
Chest radiograph (CXR) and computed tomography (CT)
showed bronchiectasis with left lower lobe collapse and
consolidation. Abdominal CT showed a fatty, atrophied
pancreas. There was no evidence of tumour recurrence.
Forced expiratory volume (FEV1) and Forced Vital capacity
(FVC) were 2.18 l/s (60% predicted) and 3.0 l (65%
predicted), respectively. Sputum and bronchoscopic lavage
cultured Mycobacterium avium complex (MAC), Stenotro-
phomonas maltophilia, Achromobacter xylosoxidans and
Aspergillus fumigatus. C reactive protein, white blood cell
count and plasma viscosity were elevated at 182 mg/l, 16
109/l and 2.5, respectively.s 5 (2006) 63 – 65ed by Elsevier B.V. All rights reserved.
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ectasis, and significant pancreatic atrophy suggested CF.
Sweat tests showed a sodium concentrations of 62 and
55 mmol/l and chloride concentrations of 56 and 48
mmol/l. Genetic analysis demonstrated N1303K and
R117H with a poly T genotype 9T/7T. Faecal pancreatic
elastase was less than 15 ı`g/g and confirming pancreatic
insufficiency. Following the introduction of nasogastric
feeding and corticosteroids for possible cryptogenic
organising pneumonia, he developed insulin dependent
diabetes mellitus.
He was treated with broad spectrum intravenous anti-
biotics, oral steroids and 18 months triple therapy for MAC
infection. Overnight nasogastric feeding was followed by
the insertion of a jejunostomy feeding tube. A year
following the diagnosis his weight had increased by 15 kg
and he has regained a good exercise tolerance.
1.2. Case 2
A 64-year-old man presented with symptoms of progres-
sive shortness of breath and increased chronic sputum
production. As a child he had suffered from persistent
cough, sinusitis and nasal polyps. He had been diagnosed
with childhood asthma and then adult bronchiectasis. At the
age of 40 years he had been forced to take early retirement
on medical grounds. There was no family history of CF.
Chest X-ray and CT demonstrated predominately upper
lobe bronchiectasis and right upper lobe fibrosis with
volume loss. Sputum grew non-mucoid P. aeruginosa. He
was pancreatic sufficient. CFTR genotype analysis revealed
delta 508 and R117H with a poly T genotype 9T/7T.
Despite several courses of intravenous and nebulised
antibiotics, he remained chronically infected with P.
aeruginosa. He was commenced on long term nebulised
colomycin, oral azithromycin and bronchodilator therapy.
Sputum volume fell dramatically and lung function, exercise
tolerance and general well-being improved.2. Discussion
Doubts have been expressed over the diagnosis of cystic
fibrosis in patients with R117H with a background 7T
polythymidine tract at intron 8. This is because the RII7H is
an exon 4 missense mutation which affects exon 9 splicing
and is influenced by the polythymidine sequence of intron
8 which precedes the splicing receptor site. This poly-
thymidine tract is polymorphic with sequences of 5, 7 and 9
thymidines [5]. Because CFTR missing exon 9 splicing is
non functional and exon-9 splicing is inversely proportional
to the length of the thymidine sequences, the 9T variant
allows normal reading of the gene while the 5T variant is
considered to be a mild mutation with incomplete pene-
trance and is associated with the highest level of non-
functional CFTR protein [5]. The commonest polymor-phism is the seven thymidine (7T) variant [2,5]. The
presence of R117H/DF508 on a background of 5T is
associated with elevated or borderline sweat test, moderate
lung disease, pancreatic exocrine sufficiency and male
infertility while R117H/DF508 in association with 7T is
associated with a normal, borderline or elevated sweat test
and variable clinical presentation [1–4,6–8] R117H in
association with 9T is very unusual but has been reported
[5].
Some authors have suggested that RII7H with a 7T allele
should not be considered as a true mutation unless
associated with a positive sweat test [9,10]. While R117H
is associated with a broad phenotype, it is often associated
with a normal or borderline sweat test despite the presence
of sino pulmonary disease. Long term follow up studies of
asymptomatic individuals are needed to clarify the risk of
developing CF in this group of patients [6,11,12]. Taylor et
al. reported the cases of three infants with DF508/R117H
genotype on a 7T/9T background identified through routine
screening. They had no sino pulmonary disease, normal
pancreatic function and sweat test results which were not
indicative of CF [13]. However on subsequent follow up
two patients developed respiratory infections with typical
CF pathogens including Staphylococcus aureus, Haemo-
philus influenzae and P .aeruginosa.3. Conclusion
The presence of two CF mutations including R117H with
a 7T allele can be associated with late presentation and
severe lung disease. Patients with this genotype should be
followed up, including sputum surveillance, to allow
appropriate early intervention by the multidisciplinary team.References
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